📊 NTRA Key Takeaways
Is Natera, Inc. (NTRA) a Good Investment?
Natera demonstrates robust 36% revenue growth with positive free cash flow ($18M) and a fortress balance sheet ($1.1B cash, 0.16x D/E), but operates at significant losses with -13.4% operating margin and -12.2% net margin, indicating structural profitability challenges at scale. The company has sufficient liquidity to sustain operations, but path to profitability remains unclear and requires material operational improvement.
Natera shows strong fundamentals with 36% revenue growth, ample liquidity, low leverage, and positive operating and free cash flow despite GAAP losses. If operating leverage continues and margins improve, the balance sheet provides sufficient runway to reach sustainable profitability.
Why Buy Natera, Inc. Stock? NTRA Key Strengths
- Strong revenue growth of 35.9% YoY demonstrates market demand and customer acquisition momentum
- Positive free cash flow of $18M and operating cash flow of $40.2M despite net losses indicates operational cash generation capability
- Fortress balance sheet with $1.1B cash reserves, very low leverage (0.16x D/E), and strong liquidity ratios (2.96x current, 2.83x quick)
- Rapid topline growth (+35.9% YoY)
- Robust liquidity and low leverage (3.39x current ratio, 0.17x D/E)
- Positive operating cash flow and FCF
NTRA Stock Risks: Natera, Inc. Investment Risks
- Severe profitability deficit: -$93.5M operating loss on $696.6M revenue with negative operating and net margins despite scale
- Razor-thin free cash flow margins at 2.6% with minimal profitability headroom relative to revenue base
- Gross profit anomaly ($723.5M exceeds revenue of $696.6M) suggests accounting complexity or data quality issues requiring clarification
- High insider activity (43 Form 4 filings in 90 days) warrants investigation for potential insider confidence concerns
- Persistent operating losses and negative interest coverage
- Gross margin pressure from reimbursement/pricing dynamics
- Higher capex needs could compress FCF if growth slows
Key Metrics to Watch
- Operating margin trajectory - critical inflection point if company can achieve breakeven or positive operating leverage from revenue growth
- Free cash flow sustainability and margin expansion - verify whether FCF improvements are achievable as company scales
- Gross profit reconciliation - resolve accounting treatment and verify no red flags in cost structure or revenue recognition
- Operating margin trajectory
- Free cash flow margin
Natera, Inc. (NTRA) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The relatively thin 2.6% FCF margin may limit capital allocation flexibility. Strong liquidity with a 2.96x current ratio provides a solid financial cushion.
NTRA Profit Margin, ROE & Profitability Analysis
NTRA vs Healthcare Sector: How Natera, Inc. Compares
How Natera, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Natera, Inc. Stock Overvalued? NTRA Valuation Analysis 2026
Based on fundamental analysis, Natera, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Natera, Inc. Balance Sheet: NTRA Debt, Cash & Liquidity
NTRA Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Natera, Inc.'s revenue has grown significantly by 269% over the 5-year period, indicating strong business expansion. The most recent EPS of $-3.78 indicates the company is currently unprofitable.
NTRA Revenue Growth, EPS Growth & YoY Performance
NTRA Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $501.8M | -$66.9M | $-0.50 |
| Q3 2025 | $439.8M | -$31.6M | $-0.26 |
| Q2 2025 | $413.4M | -$37.5M | $-0.30 |
| Q1 2025 | $367.7M | -$66.9M | $-0.50 |
| Q3 2024 | $268.3M | -$31.6M | $-0.26 |
| Q2 2024 | $261.4M | -$37.5M | $-0.30 |
| Q1 2024 | $241.8M | -$67.6M | $-0.56 |
| Q3 2023 | $210.6M | -$109.0M | $-0.95 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Natera, Inc. Dividends, Buybacks & Capital Allocation
NTRA SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Natera, Inc. (CIK: 0001604821)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NTRA
What is the AI rating for NTRA?
Natera, Inc. (NTRA) has a Combined AI Rating of BUY from Claude (HOLD) and ChatGPT (BUY) with 64% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are NTRA's key strengths?
Claude: Strong revenue growth of 35.9% YoY demonstrates market demand and customer acquisition momentum. Positive free cash flow of $18M and operating cash flow of $40.2M despite net losses indicates operational cash generation capability. ChatGPT: Rapid topline growth (+35.9% YoY). Robust liquidity and low leverage (3.39x current ratio, 0.17x D/E).
What are the risks of investing in NTRA?
Claude: Severe profitability deficit: -$93.5M operating loss on $696.6M revenue with negative operating and net margins despite scale. Razor-thin free cash flow margins at 2.6% with minimal profitability headroom relative to revenue base. ChatGPT: Persistent operating losses and negative interest coverage. Gross margin pressure from reimbursement/pricing dynamics.
What is NTRA's revenue and growth?
Natera, Inc. reported revenue of $696.6M.
Does NTRA pay dividends?
Natera, Inc. does not currently pay dividends.
Where can I find NTRA SEC filings?
Official SEC filings for Natera, Inc. (CIK: 0001604821) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NTRA's EPS?
Natera, Inc. has a diluted EPS of $-0.60.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is NTRA a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Natera, Inc. has a BUY rating with 64% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is NTRA stock overvalued or undervalued?
Valuation metrics for NTRA: ROE of -4.8% (sector avg: 15%), net margin of -12.2% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy NTRA stock in 2026?
Our dual AI analysis gives Natera, Inc. a combined BUY rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NTRA's free cash flow?
Natera, Inc.'s operating cash flow is $40.2M, with capital expenditures of $22.1M. FCF margin is 2.6%.
How does NTRA compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -12.2% (avg: 12%), ROE -4.8% (avg: 15%), current ratio 2.96 (avg: 2).